Alnylam Pharmaceuticals
ALNY
#578
Rank
NZ$56.68 B
Marketcap
$441.51
Share price
-0.48%
Change (1 day)
45.56%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cost to borrow shares

Latest borrow fee for Alnylam Pharmaceuticals (ALNY) shares on Interactive Brokers: 0.4126% (annualized)

Shares available to borrow: 2400000
The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Alnylam Pharmaceuticals (ALNY) - cost to borrow in the last 7 days chart

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow in the last 7 days

Alnylam Pharmaceuticals (ALNY) - cost to borrow from 2024 to 2023

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow from 2024 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
0.2752%2.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4206%1.9 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.25%1.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
6.9899%0.06 M๐Ÿ‡บ๐Ÿ‡ธ USA
9.1116%0.9 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.2912%0.75 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
0.4081%2 M๐Ÿ‡ซ๐Ÿ‡ท France
0.29%10 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel